ID: ALA4170629

Max Phase: Preclinical

Molecular Formula: C19H19NO2S

Molecular Weight: 325.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCSc1c(CO)cnc2ccc(OCc3ccccc3)cc12

Standard InChI:  InChI=1S/C19H19NO2S/c1-2-23-19-15(12-21)11-20-18-9-8-16(10-17(18)19)22-13-14-6-4-3-5-7-14/h3-11,21H,2,12-13H2,1H3

Standard InChI Key:  BIDHHFFSZQSXHG-UHFFFAOYSA-N

Associated Targets(Human)

Peptide N-myristoyltransferase 1 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Peptide N-myristoyltransferase 2 44 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glycylpeptide N-tetradecanoyltransferase 128 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 325.43Molecular Weight (Monoisotopic): 325.1136AlogP: 4.42#Rotatable Bonds: 6
Polar Surface Area: 42.35Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 4.30CX LogP: 3.81CX LogD: 3.81
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.68Np Likeness Score: -0.76

References

1. Goncalves V, Brannigan JA, Laporte A, Bell AS, Roberts SM, Wilkinson AJ, Leatherbarrow RJ, Tate EW..  (2017)  Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase.,  (1): [PMID:28626547] [10.1039/C6MD00531D]

Source